Mobile UPI  |   About UPI  |   UPI en Español  |   UPI Arabic  |   UPIU  |   My Account
Search:
Go

FDA rejects Byetta data

|
|
 
  
Published: Nov. 6, 2008 at 12:04 AM
Advertisement

WASHINGTON, Nov. 6 (UPI) -- The U.S. Food and Drug Administration has rejected research data for a long-acting version of the diabetes drug Byetta.

The FDA rejected Eli Lilly's studies comparing small-scale batches of Byetta LAR made by partner Alkermes to large-scale batches made at an Amylin Pharmaceuticals manufacturing plant, Amylin said. Conducting a new study could delay the company's plans to seek approval next year, the Indianapolis Star reported.

The version of Byetta currently on the market is a twice-a-day injectable drug to help diabetics control their blood sugar, the newspaper said.

Topics: Food and Drug Administration
© 2008 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.

Order reprints
  
Join the conversation
Most Popular Collections
The making of the Oscars The Chicago Auto Show 2011: The year in space
Mercedes-Benz fashion week In New York Tu Bishvat Migron settlement The Tibetan Moniam Festival in China
Additional Science News Stories
1 of 25
Meryl Streep and Colin Firth attend the "BAFTA" ceremony in London
View Caption
fark
Dads, before showing "The Smurfs" DVD from your laptop at your kid's birthday party, make sure you...
It's a Jeep thing. You wouldn't understand
Baby shower ends with three people stabbed after a drunken argument between relatives of mom-to-be...
"Man charged with exposing himself to women while riding bike" which really is a lot harder than...
Florida man ran into his ex-girlfriend yesterday. Then he backed up and ran into her again. He misses...
Adam Adamowicz, concept artist for Fallout and Skyrim, passes away after losing his fight against...